GLRE
Greenlight Capital ReCAI scenario view
RankAlpha Sentiment CodexPost-earnings T+3AI sentiment snapshot
AI commentary
This is a cautious T+3 post-earnings update. The company source clearly confirmed better underwriting, book-value growth, and ongoing buybacks, but the stock’s May 7 anchor price of $17.80 still sat below reported fully diluted book value per share of $21.40, suggesting only a muted rerating so far [#8-K-2026-05-05]. Low external coverage remains a material limitation: the packet showed no usable analyst-target set and no confirmed delayed revision wave, so missing analyst reaction should be treated as an evidence gap rather than positive confirmation.
Evidence flagged
No evidence quality warning is currently attached to this memo.
AI events
The May 5, 2026 earnings release showed net underwriting income of $6.2 million versus a loss a year ago, a combined ratio improvement to 96.0% from 104.6%, net income of $35.8 million, and fully diluted book value per share up 4.7% from year-end to $21.40, giving investors a cleaner post-earnings read on underwriting discipline and capital generation [#8-K-2026-05-05].
Management disclosed $5.0 million of buybacks in Q1 at $16.70 per share and another $9.5 million in April at $18.38, while fully diluted book value per share was reported at $21.40; continued repurchases at a discount would be incrementally supportive, but the scale is still modest for thesis change [#8-K-2026-05-05].
The operating model still depends on both underwriting execution and investment results: Q1 open-market underwriting improved materially, Innovations gross premiums written rose to $47.6 million from $27.5 million, and Solasglas contributed $33.7 million of income, but this mix also means future book-value growth remains sensitive to market and reserve outcomes [#8-K-2026-05-05] [#10-K-2026-03-09].
Recommendation
No formal recommendation provided.

